THE AUSTRALIAN: As Australians bask in the glow of Tasmanian-born Elizabeth Blackburn’s Nobel prize, a small Melbourne biotech firm is close to commercialising a diagnostic test based on her award-winning work that may¬† eventually work on prostate cancer. READ MORE>

Read Full Post »

THE AUSTRALIAN: “When was the last time the epidemiologists treated a 48-year-old man dying of prostate cancer, surrounded by a young family?” asks David Malouf, president of the Urological Society of Australia and New Zealand: “We are not talking about statistics, we are talking about human beings.” READ MORE>

In a testy debate in Australia, he was replying to critics of the society’s recent decision to follow the American Urological Association recommendation that men over 40 be offered PSA tests.

Read Full Post »